A high frequency of overexpression of human epidermal growth-factor receptor 2 (HER2) has been observed in breast cancer tissue samples obtained from atomic-bomb survivors compared with women who were not exposed to radiation35. This evidence concerns the gene ERBB2 and breast carcinoma.